title: The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study*.
abstract: In sub-Saharan Africa, sepsis is an important cause of mortality. Optimal sepsis management including fluid resuscitation, early antibiotic administration, and patient monitoring is limited by lack of supplies and skilled health workers.
  
  
  OBJECTIVE
  To evaluate whether early, monitored sepsis management provided by a study medical officer can improve survival among patients with severe sepsis admitted to two public hospitals in Uganda.
  
  
  METHODS
  A prospective before and after study of an intervention cohort (n = 426) with severe sepsis receiving early, monitored sepsis management compared to an observation cohort (n = 245) of similarly ill patients with severe sepsis receiving standard management after admission to the medical wards of two Ugandan hospitals.
  
  
  METHODS
  Early sepsis management provided by a dedicated study medical officer comprising fluid resuscitation, early antibiotics, and regular monitoring in the first 6 hrs of hospitalization.
  
  
  METHODS
  Kaplan-Meier survival and unadjusted and adjusted Cox proportional hazards analysis were used to compare the effect of early, monitored sepsis management on 30-day mortality between the intervention cohort (enrolled May 2008 to May 2009) and observation cohort (enrolled July 2006 to November 2006).
  
  
  RESULTS
  The majority (86%) of patients in both cohorts were human immuno-deficiency virus-infected. Median fluid volume provided in the first 6 hrs of hospitalization was higher in intervention than observation cohort patients (3000 mL vs. 500 mL, p < .001) and a greater proportion of intervention cohort patients received antibacterial therapy in <1 hr (67% vs. 30.4%, p < .001). Mortality at 30 days was significantly lower in the intervention cohort compared to the observation cohort (33.0% vs. 45.7%, log-rank p = .005). After adjustment for potential confounders, the hazard of 30-day mortality was 26% less in the intervention cohort compared to the observation cohort (adjusted hazards ratio 0.74, 95% confidence interval 0.55-0.98). Mortality among the 13% of intervention patients who developed signs of respiratory distress was associated with baseline illness severity rather than fluid volume administered.
  
  
  CONCLUSIONS
  Early, monitored management of severely septic patients in Uganda improves survival and is feasible and safe even in a busy public referral hospital.
authors.affiliation: Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA. sjacob2@uw.edu
authors.forename: Shevin T
authors.initials: ST
authors.lastname: Jacob
authors.forename: Patrick
authors.initials: P
authors.lastname: Banura
authors.forename: Jared M
authors.initials: JM
authors.lastname: Baeten
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Moore
authors.forename: David
authors.initials: D
authors.lastname: Meya
authors.forename: Lydia
authors.initials: L
authors.lastname: Nakiyingi
authors.forename: Rebecca
authors.initials: R
authors.lastname: Burke
authors.forename: Cheryl Lynn
authors.initials: CL
authors.lastname: Horton
authors.forename: Boaz
authors.initials: B
authors.lastname: Iga
authors.forename: Anna
authors.initials: A
authors.lastname: Wald
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Reynolds
authors.forename: Harriet
authors.initials: H
authors.lastname: Mayanja-Kizza
authors.forename: W Michael
authors.initials: WM
authors.lastname: Scheld
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001794:Blood Pressure; D005260:Female; D005440:Fluid Therapy / Q000706:statistics & numerical data; D015658:HIV Infections / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008991:Monitoring, Physiologic; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012128:Respiratory Distress Syndrome / Q000401:mortality; D018805:Sepsis / Q000401:mortality* / Q000628:therapy*; D012720:Severity of Illness Index; D014454:Uganda / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents